Global SARS-CoV-2 Expert Symposium 2022: Panel Discussion 1

Prof. Antonio Bertoletti is an expert in the field of viral hepatitis, with a specific interest in the immunopathogenesis of HBV infection and is a Professor at the Emerging Viral Disease Program at Duke-NUS Medical School, Singapore. His current research is focus on the development of new immunological based therapies (TCR-redirected T cells) for the treatment of HBV chronic infection and Hepatocellular carcinoma. In 2020, after the start of the COVID-19 pandemic, his laboratory has been actively involved in the characterization of SARS-COV2 specific T cell immune response in infected and vaccinated individuals.